Effect of Apolipoprotein E Gene Polymorphism on Lipid and Essential Hypertension
Ying Liu
Abstract
Ying Liu
Abstract
Aim To explore the effect of apolipoprotein E (Apo E) polymorphism on lipid and essential hypertension. Methods Polymerase chain reaction restricted fragments length polymorphism was used to determine the Apo E genotypes in 112 cases with essential hypertension and 118 controls without hypertension. Results The e4 allele frequency and the Apo E e4 carriers was significantly higher in the hypertensive patient group than that in the group of normotensive control (P0.05). The subjects carrying Apo E e4 had significantly higher levels of total cholesterol (TC) and low density lipoprotein cholesterol (LDLC) than those carrying Apo E e2 (P0.05);the Apo E e3/e3 carriers had significantly higher LDLC levels than the Apo E e2 carriers (P0.05). The Apo E e4 was an independent risk factor for essential hypertension (P0.05). Conclusions The Apo E gene polymorphism affects plasma levels of lipids and lipoproteins. The Apo E e4 may be an important risk factor for essential hypertension.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Aim To explore the effect of apolipoprotein E (Apo E) polymorphism on lipid and essential hypertension. Methods Polymerase chain reaction restricted fragments length polymorphism was used to determine the Apo E genotypes in 112 cases with essential hypertension and 118 controls without hypertension. Results The e4 allele frequency and the Apo E e4 carriers was significantly higher in the hypertensive patient group than that in the group of normotensive control (P0.05). The subjects carrying Apo E e4 had significantly higher levels of total cholesterol (TC) and low density lipoprotein cholesterol (LDLC) than those carrying Apo E e2 (P0.05);the Apo E e3/e3 carriers had significantly higher LDLC levels than the Apo E e2 carriers (P0.05). The Apo E e4 was an independent risk factor for essential hypertension (P0.05). Conclusions The Apo E gene polymorphism affects plasma levels of lipids and lipoproteins. The Apo E e4 may be an important risk factor for essential hypertension.
Key concepts: Essential hypertension, Genotype, Internal medicine, Allele, Apolipoprotein B, Apolipoprotein E, Endocrinology, Polymorphism (computer science)